Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

Molecular Partners Ag (MOLN) Operating Expenses (2021 - 2025)

Historic Operating Expenses for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$15057.1.

  • Molecular Partners Ag's Operating Expenses rose 1456.82% to -$15057.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $54.7 million, marking a year-over-year decrease of 487.09%. This contributed to the annual value of $75.2 million for FY2024, which is 206.94% down from last year.
  • According to the latest figures from Q3 2025, Molecular Partners Ag's Operating Expenses is -$15057.1, which was up 1456.82% from -$20.9 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Operating Expenses registered a high of $76.9 million during Q4 2023, and its lowest value of -$43.0 million during Q2 2021.
  • Moreover, its 5-year median value for Operating Expenses was -$17829.0 (2021), whereas its average is $6.7 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 29921.52% in 2022, then tumbled by 18952.71% in 2023.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Operating Expenses stood at $19.0 million in 2021, then surged by 299.22% to $75.8 million in 2022, then grew by 1.4% to $76.9 million in 2023, then fell by 1.65% to $75.6 million in 2024, then plummeted by 100.02% to -$15057.1 in 2025.
  • Its last three reported values are -$15057.1 in Q3 2025, -$20.9 million for Q2 2025, and -$17953.9 during Q1 2025.